86 results
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
15 May 24
Bio-Path Holdings Reports First Quarter 2024 Financial Results
7:10am
primarily due to decreased manufacturing expenses related to drug product releases partially offset by an increase in expense related to our clinical trial
8-K
EX-99.1
akogi m7s0etq
15 Nov 23
Bio-path Holdings Reports Third Quarter 2023 Financial Results
7:30am
8-K
EX-99.1
amh ncjmtx2e
11 Mar 22
Bio-path Holdings Reports Full Year 2021 Financial Results
7:30am
DEFA14A
7rx03
4 Nov 21
Additional proxy soliciting materials
4:55pm